Use of 2,4,5-tri(4-methoxyphenyl)-4,5-dihydroimidazole for the treatment of cancer
申请人:MARION MERRELL DOW INC.
公开号:EP0433682A2
公开(公告)日:1991-06-26
2,4,5-Tri(4-methoxyphenyl)4,5-dihydroimidazole, or a pharmaceutically acceptable salt thereof, is employed as a cancer drug potentiator or as an antimetastis drug.